Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study

Affiliations

• ¹ Department of Pathophysiology and Transplantation, Università Degli Studi di Milano, Italy (P.A., F.P., C.M.).
• ² Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy (P.A., F.G., S.M.P., M.A., P.B., F.P.).
• ³ Academic Unit of Injury, Recovery and Inflammation Sciences, Rheumatology, School of Medicine, University of Nottingham, United Kingdom (A.K., A.M.V.).
• ⁴ NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, United Kingdom (A.K., A.M.V.).
• ⁵ Internal Medicine and Alcohol Related Disease Unit, Columbus-Gemelli Hospital (T.D., G.A.), Fondazione Policlinico Universitario A. Gemelli IRCCS, Italy.
• ⁶ Department of Medical and Surgical Sciences, Università Cattolica di Roma, Italy (G.A.).
• ⁷ Unit of Hemostasis and Thrombosis (L.D.I., S.S., E.D.C.), Fondazione Policlinico Universitario A. Gemelli IRCCS, Italy.
• ⁸ Department of Laboratory and Infectious Sciences (F.D.M.), Fondazione Policlinico Universitario A. Gemelli IRCCS, Italy.
• ⁹ Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Italy (E.D.C.).
• ¹⁰ PreBiomics S.r.l., Italy (A.B.-M., D.B., A.B., G.T., M.B.).
• ¹¹ Department of Twin Research and Genetic Epidemiology, King's College London, United Kingdom (C.M.).